Showing posts with label glucagon. Show all posts
Showing posts with label glucagon. Show all posts

Monday, 2 June 2025

Pathophysiology and Complications of Portal Hypertension in Liver Cirrhosis | Chapter 7 | Medical Science: Recent Advances and Applications Vol. 5

Portal hypertension is responsible for most of the complications that mark the transition from compensated to decompensated cirrhosis, namely variceal haemorrhage, ascites and hepatic encephalopathy. Portal hypertension also seems to be pathogenetically closely linked to the development of pulmonary complications seen in liver disease: hepatopulmonary syndrome and porto-pulmonary hypertension.

 

Gastroesophageal varices result almost solely from portal hypertension, although the hyperdynamic circulation contributes to variceal growth and rupture. Ascites results from sinusoidal hypertension (portal hypertension) and sodium retention, which is, in turn, secondary to vasodilatation and activation of neurohumoral systems. The predictive value of noninvasive methods such as fibroscan, spleen size, portal vein diameter, and transient elastography in the diagnosis of oesophagal varices remains to be established. Hepatorenal syndrome results from extreme vasodilatation with extreme decrease in effective blood volume and maximal activation of vasoconstrictive systems, renal vasoconstriction, and renal failure, which is probably an indirect effect of the changes in splanchnic circulation. Spontaneous bacterial peritonitis, a frequent precipitant of the hepatorenal syndrome, results from deficient immunity and mucosal defences, resulting in pathological gut bacterial translocation. Hepatic encephalopathy results from portosystemic shunting and hepatic insufficiency, leading to the accumulation of neurotoxins, mainly ammonia, in the brain. The development of portal hypertension and its complications has important prognostic value. Management of portal hypertension needs to be individualised to attain maximum benefit and appropriate utilisation of scarce resources.

 

 

Author (s) Details

Harshal Rajekar
Medicover Hospitals, KLE, Bhosari, Pune, India.

 

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v5/5542

Wednesday, 14 June 2023

Euglycemic Ketoacidosis due to Pancreatitis in a Patient without Diabetes | Chapter 14 | New Advances in Medicine and Medical Science Vol. 5

 We are detailing the case related to earlier healthy 40- year-traditional Female with a popular medical history of essential hypertension (HTN) and outside previous history of Diabetes Mellitus(DM). She was communicable for her HTN – Amlodipine 5 mg once a day. The patient bestowed in our Emergency Department with intestinal pain, pleuritic chest pain, nausea and disgorging. She also objected of shortness of respiration, generalized weakness and had inferior fever. On review of arrangements she was also erect to be diaphoretic and bearing Kussmaul respiration.After the lab studies were obtained she was erect to have severe metabolic upset stomach and was admitted to the Intensive care unit.The differential disease of her metabolic acidosis was broad, but she acted not have DM – her HbA1c was 5.2% and she was not drinking intoxicating. The screening for Methanol and ethylene glycol was negative. The patient did not have latent kidney or liver ailment.Also she did not have infection of blood with lactic acidosis to expound her severe metabolic upset stomach. She did not have likewise prolonged starvation. The drug screen of the patient was negative and she was not communicable any cure to explain her metabolic upset stomach.We are describing this case with harsh metabolic acidosis, cause we have found that the cause was harsh acute pancreatitis. The cause of the acute pancreatitis was not establish. It was not related to intoxicating, increased triglycerides or some medications. Her ultrasound of the gall bladder was negative for gall pouch stones but gently elevated ALT and AST ability have been related to gived gall bladder mud as a cause of her acute pancreatitis.The harsh metabolic ketoacidosis due to acute pancreatitis is the disputing diagnosis and only few cases were detailed in the literature.The method of acute pancreatitis causing harsh metabolic acidosis appears to be had connection with the lipolytic action of inflated lipase as well as increased glucagon and nearly decreased Insulin in the synopsis of acute pancreatic damage.

Author(s) Details:

Andre Manov,
Sunrise Health Care Consortium GME, Mountain View Hospital, North Tenaya Way, Las Vegas, Nevada, 2880, USA.

Ikechukwu Ogbu,
Sunrise Health Care Consortium GME, Mountain View Hospital, North Tenaya Way, Las Vegas, Nevada, 2880, USA.

Please see the link here: https://stm.bookpi.org/NAMMS-V5/article/view/10874